NIH: A Look Back at Science's 2022 Breakthroughs

In the following post from the NIH Director's blog, Lawrence Tabak, DDS, PhD, discusses breakthroughs on RSV vaccines, advancements in MS research, and using AI to design novel proteins for vaccines and other uses.

Happy New Year! I hope everyone finished 2022 with plenty to celebrate, whether it was completing a degree or certification, earning a promotion, attaining a physical fitness goal, or publishing a hard-fought scientific discovery.

If the latter, you are in good company. Last year produced some dazzling discoveries, and the news and editorial staff at the journal Science kept a watchful eye on the most high-impact advances of 2022. In December, the journal released its list of the top 10 advances across the sciences, from astronomy to zoology. In case you missed it, Science selected NASA's James Webb Space Telescope (JWST) as the 2022 Breakthrough of the Year.

While the biomedical sciences didn't take home the top prize, they were well represented among Science's runner-up breakthroughs. Some of these biomedical top contenders also have benefited, directly or indirectly, from NIH efforts and support. Let's take a look:

RSV vaccines nearing the finish line . . .
Virus fingered as cause of multiple sclerosis . . .
AI gets creative . . .

Read more at directorsblog.nih.gov.